Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Feb;82(1):134-40.
doi: 10.1016/j.rvsc.2006.03.007. Epub 2006 May 30.

Oral efficacy of Vero cell attenuated porcine epidemic diarrhea virus DR13 strain

D S Song  1 , J S Oh, B K Kang, J S Yang, H J Moon, H S Yoo, Y S Jang, B K Park
Affiliations

Oral efficacy of Vero cell attenuated porcine epidemic diarrhea virus DR13 strain

D S Song et al. Res Vet Sci. 2007 Feb.

Abstract

A Vero cell attenuated porcine epidemic diarrhea virus (PEDV) strain, DR13, was distinguished from wild-type PEDV using restriction enzyme fragment length polymorphism (RFLP). Cell attenuated DR13 was orally or intramuscularly (IM) administered to late-term pregnant sows, and mortality resulting from the highly virulent PEDV challenge was investigated in passively immunized suckling piglets of the two different groups. The mortality rate of the oral group (13%) was lower than that of the IM group (60%). In particular, the concentration of IgA against PEDV was higher in piglets of sows in the oral group, compared to the IM group. The attenuated DR13 virus remained safe, even after three backpassages in piglets. The findings of this study support the theory that the Vero cell attenuated DR13 virus may be applied as an oral vaccine for inducing specific immunity in late-term pregnant sows with a high margin of protection against PEDV infection.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Immune responses of serum samples from pregnant sows inoculated with Vero cell attenuated PEDV DR13, using IgA-specific ELISA (1A; A farm, 1B; B farm). ∗P < 0.05.
Fig. 2A
Fig. 2A
Antibody responses from serum samples observed with the SN test against the porcine epidemic diarrhea virus in pregnant sows. Titers are presented as means ± SD.
Fig. 2B
Fig. 2B
Antibody responses from colostrums observed with the SN test against the porcine epidemic diarrhea virus in pregnant sows. Titers are presented as means ± SD (∗P < 0.05).
Fig. 3
Fig. 3
Antibody responses from serum samples against porcine epidemic diarrhea virus in 3-day-old piglets using IgG and IgA-specific ELISA before challenge exposure (∗P < 0.05).
Fig. 4
Fig. 4
Antibody responses from serum samples against porcine epidemic diarrhea virus in 3-day-old piglets using the SN test before challenge exposure (∗P < 0.05).
See this image and copyright information in PMC

References

    1. Bae J.L., Lee J.G., Kang T., Jang H.S., Jang Y.S., Yang M.S. Induction of antigen specific systemic and mucosal immune responses by feeding animals transgenic plants expressing antigen. Vaccine. 2003;21:4052–4058. - PubMed
    1. De Arriba M.L., Carvajal A., Lanza I., Rubio P., Carmens P. Development of an ELISA for the detection of antibody isotypes against porcine epidemic diarrhea virus (PEDV) in sow’s milk. In Immunology of viral infections. Proc. Congr. Eur. Soc. Vet. Virol. 1995;3:222–225.
    1. De Arriba M.L., Carvajal A., Pozo J., Rubio P. Mucosal and systemic isotype-specific antibody responses and protection in conventional pigs exposed to virulent or attenuated porcine epidemic diarrhea virus. Vet. Immunol. Immunopathol. 2002;85:85–97. - PubMed
    1. Debouck P., Pensaert M. Experimental infection of pigs with a new porcine enteric coronavirus CV777. Am. J. Vet. Res. 1980;41:219–223. - PubMed
    1. Ducatelle R., Coussement W., Pensaert M., Debouck P., Hoorens J. In vivo morphogenesis of a new porcine enteric coronavirus, CV777. Arch. Virol. 1981;68:35–44. - PMC - PubMed

Publication types

MeSH terms